Keeping sterile 0.9% sodium chloride, 5% dextrose, and lactated Ringer’s solutions for injection cold enough for dilution of decitabine in isolators

Autor: Florian Correard, Bertrand Pourroy, Pascale Pisano, Amandine Savry, Laurence Gauthier Villano, Fabien Espitallier

Publikováno v: American Journal of Health-System Pharmacy
American Journal of Health-System Pharmacy, American Society of Health-System Pharmacists, 2016, 73 (11), pp.748-750. ⟨10.2146/ajhp140625⟩
American Journal of Health-System Pharmacy, 2016, 73 (11), pp.748-750. ⟨10.2146/ajhp140625⟩

Decitabine is indicated for the treatment of newly diagnosed de novo or secondary acute myeloid leukemia in adults age 65 years or older who are not candidates for standard induction chemotherapy.[1][1] The decitabine powder must be aseptically recon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419519e80adde06e7a284cdc8d3e5242
https://doi.org/10.2146/ajhp140625